COVID-19 vaccine maker BioNTech reports $1.37 billion profit in Q1

German pharmaceutical company BioNTech reported a net profit of 1.13 billion euros ($1.37 billion) in the first quarter of this year on the back of strong revenues from its coronavirus vaccine.